Literature DB >> 9226186

Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation.

A Heitger1, N Neu, H Kern, E R Panzer-Grümayer, H Greinix, D Nachbaur, D Niederwieser, F M Fink.   

Abstract

To contribute to the understanding of the role of the thymus in humans in the reconstitution of naive (CD45RA+) T cells after bone marrow transplantation (BMT), we compared T-cell regeneration in a unique situation, namely a thymectomized cancer patient (15 years old), with that of thymus-bearing patients after allogeneic BMT. These cases shared features of transplantation (total body irradiation, HLA-matched donors, and graft-versus-host disease prophylaxis with cyclosporine A) and all had an uncomplicated post-transplantation course. As shown by fluorescence-activated cell sorting analyses, the thymectomized host failed to reconstitute CD45RA+ T-helper cells even 24 months after BMT (11% CD45RA+ of CD4+ cells). In this patient, preferentially CD45RO+ cells contributed to the recovery of CD4+ cells (206 of 261/microL at 6 months and 463 of 558/microL at 24 months after BMT, CD45RA+ of CD4+ cells), whereas CD45RA+ cells remained low (<60/microL). In contrast, nine thymus-bearing hosts (5 children and 4 adults) examined between 6 and 24 months after BMT effectively reconstituted CD4+/CD45RA+ cells according to their normal age-related range (> or = 28% in adults and > or = 50% in children). Five of these were analyzed sequentially at 6 and 9 months after BMT. Within this period, CD45RA+ cells increasingly contributed to the recovery of CD4+ cells (median, +21%), even when total CD4+ cells decreased. With respect to T-cytotoxic/suppressor cells, the thymectomized host retained the capacity to recover CD45RA+ cells (137 of 333/microL at 6 months and 596 of 1,046/microL at 24 months after BMT, CD45RA+ of CD8+ cells), a proportion similar to that seen in thymus-bearing hosts. These findings suggest that a thymus-independent pathway exists to regenerate CD45RA+ T-cytotoxic/suppressor cells, but residual thymus is essential to reconstitute naive (CD45RA+) T-helper cells after BMT in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9226186

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  CD34+-selected autologous peripheral blood stem cell transplantation conditioned with total body irradiation for malignant lymphoma: increased risk of infectious complications.

Authors:  S Maeda; Y Kagami; M Ogura; H Taji; R Suzuki; E Kondo; S Asakura; T Takeuchi; K Miura; M Ando; S Nakamura; T Ito; T Kinoshita; R Ueda; Y Morishima
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

2.  Thymic function-related markers within the thymus and peripheral blood: Are they comparable?

Authors:  María Victoria Arellano; Antonio Ordóñez; Ezequiel Ruiz-Mateos; Santiago R Leal-Noval; Sonia Molina-Pinelo; Ana Hernández; Alejandro Vallejo; Rafael Hinojosa; Manuel Leal
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.317

3.  Rabbit antithymocyte globulin (thymoglobulin) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients.

Authors:  Il-Kang Na; Friedrich Wittenbecher; Mikalai Dziubianau; Anne Herholz; Angela Mensen; Désirée Kunkel; Olga Blau; Igor Blau; Eckhard Thiel; Lutz Uharek; Carmen Scheibenbogen; Kathrin Rieger; Andreas Thiel
Journal:  Haematologica       Date:  2012-07-16       Impact factor: 9.941

4.  OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.

Authors:  R M van Praag; J M Prins; M T Roos; P T Schellekens; I J Ten Berge; S L Yong; H Schuitemaker; A J Eerenberg; S Jurriaans; F de Wolf; C H Fox; J Goudsmit; F Miedema; J M Lange
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

5.  Longitudinal analysis of immune function in the first 3 years of life in thymectomized neonates during cardiac surgery.

Authors:  E Mancebo; J Clemente; J Sanchez; J Ruiz-Contreras; P De Pablos; S Cortezon; E Romo; E Paz-Artal; L M Allende
Journal:  Clin Exp Immunol       Date:  2008-09-22       Impact factor: 4.330

6.  Decreased levels of recent thymic emigrants in peripheral blood of simian immunodeficiency virus-infected macaques correlate with alterations within the thymus.

Authors:  Donald L Sodora; Jeffrey M Milush; Felecia Ware; Aneta Wozniakowski; Lisa Montgomery; Harold M McClure; Andrew A Lackner; Marta Marthas; Vanessa Hirsch; R Paul Johnson; Daniel C Douek; Richard A Koup
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Comparison of different rabbit ATG preparation effects on early lymphocyte subset recovery after allogeneic HSCT and its association with EBV-mediated PTLD.

Authors:  Angela Mensen; Il-Kang Na; Ralf Häfer; Astrid Meerbach; Maria Schlecht; Marie-Luise Pietschmann; Bernd Gruhn
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-25       Impact factor: 4.553

8.  Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease.

Authors:  Xiao Chen; Rupali Das; Richard Komorowski; Amy Beres; Martin J Hessner; Masahiko Mihara; William R Drobyski
Journal:  Blood       Date:  2009-06-02       Impact factor: 22.113

9.  The influence of different types of alcoholic beverages on disrupting highly active antiretroviral treatment (HAART) outcome.

Authors:  María José Míguez-Burbano; John E Lewis; Joel Fishman; Deshratn Asthana; Robert M Malow
Journal:  Alcohol Alcohol       Date:  2009-05-18       Impact factor: 2.826

10.  Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells.

Authors:  Martin Guimond; Rachelle G Veenstra; David J Grindler; Hua Zhang; Yongzhi Cui; Ryan D Murphy; Su Young Kim; Risu Na; Lothar Hennighausen; Sema Kurtulus; Batu Erman; Polly Matzinger; Melinda S Merchant; Crystal L Mackall
Journal:  Nat Immunol       Date:  2009-01-11       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.